{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:05:41Z","timestamp":1790197541757,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.nbd.2020.105026","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T21:19:17Z","timestamp":1595539157000},"page":"105026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["PI3K isoform-selective inhibition in neuron-specific PTEN-deficient mice rescues molecular defects and reduces epilepsy-associated phenotypes"],"prefix":"10.1016","volume":"144","author":[{"given":"Angela R.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durgesh","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly C.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve C.","family":"Danzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-2527","authenticated-orcid":false,"given":"Christina","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.105026_bb0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ng782","article-title":"Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease","volume":"29","author":"Backman","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2020.105026_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/BJ20111741","article-title":"Both p110alpha and p110beta isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor","volume":"442","author":"Berenjeno","year":"2012","journal-title":"Biochem. J."},{"issue":"75","key":"10.1016\/j.nbd.2020.105026_bb0015","article-title":"Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function","volume":"8","author":"Biever","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2020.105026_bb0020","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2020.105026_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jmg.2004.024646","article-title":"Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations","volume":"42","author":"Butler","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2020.105026_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.nbd.2020.105026_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046044","article-title":"Impact of corticosterone treatment on spontaneous seizure frequency and epileptiform activity in mice with chronic epilepsy","volume":"7","author":"Castro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.105026_bb0040","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41591-019-0608-y","article-title":"Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency","volume":"25","author":"Chen","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2020.105026_bb0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","article-title":"The mTOR signalling cascade: paving new roads to cure neurological disease","volume":"12","author":"Crino","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2020.105026_bb0050","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/hmg\/ddp092","article-title":"Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder","volume":"18","author":"Cusco","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105026_bb0055","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2020.105026_bb0060","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1073\/pnas.0906461107","article-title":"Activity of any class IA PI3K isoform can sustain cell proliferation and survival","volume":"107","author":"Foukas","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105026_bb0065","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/mp.2014.125","article-title":"Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism","volume":"20","author":"Frazier","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2020.105026_bb0070","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","article-title":"Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation","volume":"23","author":"Furet","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2020.105026_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2016.03.010","article-title":"Rapamycin prevents, but does not reverse, aberrant migration in Pten knockout neurons","volume":"93","author":"Getz","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105026_bb0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2004.02.005","article-title":"Neuronal density, size and shape in the human anterior cingulate cortex: a comparison of Nissl and NeuN staining","volume":"63","author":"Gittins","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2020.105026_bb0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ajmg.1477","article-title":"PTEN mutation in a family with Cowden syndrome and autism","volume":"105","author":"Goffin","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.nbd.2020.105026_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2119\/molmed.2011.00363","article-title":"Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110beta-selective inhibitor","volume":"18","author":"Gross","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.nbd.2020.105026_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2014.00012","article-title":"Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders","volume":"7","author":"Gross","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2020.105026_bb0100","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1523\/JNEUROSCI.0402-10.2010","article-title":"Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome","volume":"30","author":"Gross","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105026_bb0105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.celrep.2015.03.065","article-title":"Selective role of the catalytic PI3K subunit p110beta in impaired higher order cognition in fragile X syndrome","volume":"11","author":"Gross","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2020.105026_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41386-018-0150-5","article-title":"Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model","volume":"44","author":"Gross","year":"2019","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.nbd.2020.105026_bb0115","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/epi.16370","article-title":"GATORopathies: the role of amino acid regulatory gene mutations in epilepsy and cortical malformations","volume":"60","author":"Iffland","year":"2019","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2020.105026_bb0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07091","article-title":"Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis","volume":"454","author":"Jia","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.105026_bb0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng781","article-title":"Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease","volume":"29","author":"Kwon","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2020.105026_bb0130","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1073\/pnas.2132711100","article-title":"mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo","volume":"100","author":"Kwon","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105026_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2006.03.023","article-title":"Pten regulates neuronal arborization and social interaction in mice","volume":"50","author":"Kwon","year":"2006","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2020.105026_bb0140","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.1206118109","article-title":"Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110delta inhibition as a potential therapeutic strategy","volume":"109","author":"Law","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105026_bb0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature05453","article-title":"Genome-wide atlas of gene expression in the adult mouse brain","volume":"445","author":"Lein","year":"2007","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2020.105026_bb0150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nm.3824","article-title":"Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy","volume":"21","author":"Lim","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2020.105026_bb0155","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neuroscience.2013.07.037","article-title":"Focal malformations of cortical development: new vistas for molecular pathogenesis","volume":"252","author":"Lim","year":"2013","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2020.105026_bb0160","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.bmcl.2012.01.092","article-title":"Synthesis and structure-activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitors","volume":"22","author":"Lin","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2020.105026_bb0165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","article-title":"Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia","volume":"2","author":"Ljungberg","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.nbd.2020.105026_bb0170","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.105026_bb0175","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1158\/1078-0432.CCR-17-0725","article-title":"A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase Beta-selective inhibitor, in patients with advanced solid tumors","volume":"23","author":"Mateo","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.nbd.2020.105026_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/aur.132","article-title":"Confirmation study of PTEN mutations among individuals with autism or developmental delays\/mental retardation and macrocephaly","volume":"3","author":"McBride","year":"2010","journal-title":"Autism Res."},{"key":"10.1016\/j.nbd.2020.105026_bb0185","doi-asserted-by":"crossref","first-page":"15704","DOI":"10.1523\/JNEUROSCI.2392-12.2012","article-title":"Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis","volume":"32","author":"McMahon","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105026_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1471-4159.2004.02302.x","article-title":"PIP3 is involved in neuronal polarization and axon formation","volume":"89","author":"Menager","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.105026_bb0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.nbd.2020.105026_bb0200","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1523\/JNEUROSCI.0937-07.2007","article-title":"Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome","volume":"27","author":"Muddashetty","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105026_bb0205","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1007\/s00216-014-7790-z","article-title":"New in-capillary electrophoretic kinase assays to evaluate inhibitors of the PI3k\/AKT\/mTOR signaling pathway","volume":"406","author":"Nehme","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.nbd.2020.105026_bb0210","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/epi.12946","article-title":"mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia","volume":"56","author":"Nguyen","year":"2015","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2020.105026_bb0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2017.04.026","article-title":"Differential roles for AKT and mTORC1 in the hypertrophy of Pten mutant neurons, a cellular model of brain overgrowth disorders","volume":"354","author":"Nikolaeva","year":"2017","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2020.105026_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ajhg.2014.03.018","article-title":"Convergence of genes and cellular pathways dysregulated in autism spectrum disorders","volume":"94","author":"Pinto","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2020.105026_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-015-0066-4","article-title":"Increased expression of the PI3K catalytic subunit p110delta underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family","volume":"7","author":"Poopal","year":"2016","journal-title":"Mol. Autism."},{"key":"10.1016\/j.nbd.2020.105026_bb0230","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neuron.2012.08.002","article-title":"Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy","volume":"75","author":"Pun","year":"2012","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2020.105026_bb0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036780","article-title":"PTEN in autism and neurodevelopmental disorders","volume":"9","author":"Rademacher","year":"2019","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.nbd.2020.105026_bb0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12703","article-title":"Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy","volume":"4","author":"Roy","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2020.105026_bb0245","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.4049\/jimmunol.170.5.2647","article-title":"Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement","volume":"170","author":"Sadhu","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.105026_bb0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-006-0128-y","article-title":"Activation of AKT independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias","volume":"112","author":"Schick","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"Suppl. 5","key":"10.1016\/j.nbd.2020.105026_bb0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1528-1167.2007.01291.x","article-title":"Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions","volume":"48","author":"Schick","year":"2007","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2020.105026_bb0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nmeth.1314","article-title":"SUnSET, a nonradioactive method to monitor protein synthesis","volume":"6","author":"Schmidt","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2020.105026_bb0265","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1113\/jphysiol.2011.220236","article-title":"Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration","volume":"590","author":"Sperow","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2020.105026_bb0270","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1528-1167.2011.03280.x","article-title":"Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice","volume":"52","author":"Sunnen","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2020.105026_bb0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2020.105026_bb0280","article-title":"MicroRNA inhibition upregulates hippocampal A-type potassium current and reduces seizure frequency in a mouse model of epilepsy","volume":"104508","author":"Tiwari","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105026_bb0285","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0092-8674(00)81826-7","article-title":"Subregion- and cell type-restricted gene knockout in mouse brain","volume":"87","author":"Tsien","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.nbd.2020.105026_bb0290","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm2882","article-title":"The emerging mechanisms of isoform-specific PI3K signalling","volume":"11","author":"Vanhaesebroeck","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2020.105026_bb0295","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.0802655105","article-title":"PTEN-deficient cancers depend on PIK3CB","volume":"105","author":"Wee","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105026_bb0300","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/jid.2010.327","article-title":"Vertical inhibition of the mTORC1\/mTORC2\/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo","volume":"131","author":"Werzowa","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.nbd.2020.105026_bb0305","first-page":"1496","article-title":"Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC)","volume":"5","author":"Wong","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.nbd.2020.105026_bb0310","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.celrep.2017.06.054","article-title":"CRKL mediates p110beta-dependent PI3K signaling in PTEN-deficient cancer cells","volume":"20","author":"Zhang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2020.105026_bb0315","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","article-title":"Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice","volume":"29","author":"Zhou","year":"2009","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120303016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120303016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:20:39Z","timestamp":1760851239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120303016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":63,"alternative-id":["S0969996120303016"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105026","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI3K isoform-selective inhibition in neuron-specific PTEN-deficient mice rescues molecular defects and reduces epilepsy-associated phenotypes","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105026"}}